Astrazeneca is yellow, Pfizer green: Hungary's Covid vaccine-themed treats

At a patisserie in the small town of Vere­segyhaz, the choice is between a selection of layered mousses with colourful jelly toppings, presented in small glasses, with decorative syringes on top

Covid-19, coronavirus, vaccine-themed pastry, sweet mousses, hungary
Each colour of jelly represents a different Covid-19 vaccine: citrus yellow for Astra­Zeneca and a slightly darker yellow for Sinopharm, matcha green for Pfizer, orange for Sputnik V and a vivid blue for Moderna | Photo: Twitter
Reuters Veresegyhaz, Hungary
2 min read Last Updated : Apr 20 2021 | 11:42 PM IST
A Hungarian pastry shop has launched a range of Covid-19 vaccine-themed sweet mousses as a light-hearted antidote to angst over the different types of vaccines and the implications of receiving one or another of them.

At the Sulyan family’s patisserie in the small town of Vere­segyhaz, northeast of Buda­pest, the choice is between a selection of layered mousses with colourful jelly toppings, presented in small glasses, with decorative syringes on top.

Each colour of jelly represents a different Covid-19 vaccine: citrus yellow for Astra­Zeneca and a slightly darker yellow for Sinopharm, matcha green for Pfizer, orange for Sputnik V and a vivid blue for Moderna.

These sweet offerings from the Sulyan family come at a time when millions of Hungar­ians are being asked to go thro­ugh a registration process to sign up for vaccination, whilst debating the merits of the different vaccines being rolled out.

People are not being given a choice of shots but rather re­ceive whichever one is available from their family doctor. In recent weeks, thousands have joined Facebook support gro­ups to connect with others who have received the same shots as they have. “Here peop­le have a choice, there is no registration, there are no side-effects,” said confectioner Katalin Ben­ko at the Sulyan patisserie.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :HungaryCoronavirus VaccineAstraZenecaPfizer

Next Story